C210S (p.Cys210Ser) variant of ITGB3 (Integrin beta-3)

C210S (p.Cys210Ser) in ITGB3 (Integrin beta-3) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic in the context of Glanzmann thrombasthenia. The available variant effect predictions contribute to a CATVariant prioritization score of 0.86 / 1. The record also includes structural context.

C210S (p.Cys210Ser) variant details